Definitive Contract 75A50119C00016
Award Date
7/1/19
Potential Completion Date
11/10/23
Potential Value
$95M
Awardee
Chrysalis Biotherapeutics, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Galveston, TX 77550, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Battelle Memorial Institute. The $2,611,477.00 cost-plus-fixed-fee contract is for non-GLP dose-range finding and GLP toxicity studies in minipigs, as well as in vitro drug-drug interaction studies for a small peptide. The contract was awarded under the Manufacturing and Nonclinical Studies Support for the...
This is a delivery order issued under the "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" IDIQ contract by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The $634,385.25 award to Battelle Memorial Institute, a non-profit research and development organization, is for a 13-hour cardiovascular and pulmonary safety pharmacology study of the drug candidate HBN-1 using telemetered...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Chrysalis Biotherapeutics, Inc. The contract is for "A NOVEL NUCLEAR COUNTERMEASURE TARGETING ENDOTHELIAL CELLS AND STEM CELLSTO COMBAT ARS AND DELAYED MULTIPLE ORGAN DYSFUNCTION" and has a ceiling value of $6,954,508.60. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and has an ultimate completion date of August 31, 2021. The...
This is a $65,806,649.98 cost-plus-fixed-fee definitive contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Biofactura Inc., a for-profit manufacturer located in Frederick, Maryland. The contract includes preclinical and manufacturing development activities such as cell line development, process development, non-clinical efficacy and safety studies, manufacturing, and clinical activities. The contract has an...
This is a $10,299,171.18 cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Humanetics Corp, a for-profit biopharmaceutical company. The contract is for an NHP (non-human primate) efficacy study of BIO 300, a therapeutic candidate being developed by Humanetics to mitigate radiation-induced pneumonitis and pulmonary fibrosis. This work builds on Humanetics' prior federal grants from agencies like NIH, DoD, and the Army for research and...
This firm fixed price purchase order for $949,800 was awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Mattek Corporation. The contract calls for the delivery of 600 EpiAirway 3D respiratory epithelial non-human primate microtissues and 600 EpiAlveolar 3D small airway non-human primate microtissues to support SARS-CoV-2 variant and therapeutics testing being conducted by the National Institute on Drug...
This is a $4,626,893.20 delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Battelle Memorial Institute. The contract is for the evaluation of filovirus vaccines in general use prophylaxis (GUP) immunogenicity and filovirus challenge studies. Key subcontractors include Integrated Biotherapeutics, LLC, a small disadvantaged business, which provided services related to filovirus...
This is a $85,000,000 Firm Fixed Price delivery order awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency. The task order is part of a larger $20 billion Biopharmaceutical Manufacturing Preparedness Consortium contract for the Department of Health and Human Services. Advanced Technology International, a public service nonprofit, is the prime contractor. The order involves the delivery of specialized services in areas such as pharmaceutical...
This firm fixed-price purchase order contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Envigo Global Services Inc., a subsidiary of Inotiv, Inc. The $6,865,791 award is for the housing, management, and transportation of 338 non-human primates prior to transfer to network laboratories for non-clinical studies. This work supports critical biomedical research and public health preparedness efforts related...
This federal contract award to Premier Biosource, Inc., a for-profit organization, was made by the Defense Health Agency (DHA) to provide 16 pigs for research purposes. The contract, valued at $10,970.00, is structured as a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type. Premier Biosource, Inc. is the prime contractor, and the contract does not involve any set-aside designation. The award has an ultimate completion date of September 30, 2024, and is part of a larger...